Synthesis and use of an amphiphilic dendrimer for siRNA delivery into primary immune cells

被引:35
|
作者
Chen, Jiaxuan [1 ,2 ,3 ]
Ellert-Miklaszewska, Aleksandra [4 ]
Garofalo, Stefano [5 ]
Dey, Arindam K. [6 ]
Tang, Jingjie [1 ]
Jiang, Yifan [1 ]
Clement, Flora [6 ]
Marche, Patrice N. [6 ]
Liu, Xiaoxuan [2 ,3 ]
Kaminska, Bozena [4 ]
Santoni, Angela [7 ]
Limatola, Cristina [5 ,7 ]
Rossi, John J. [8 ]
Zhou, Jiehua [8 ]
Peng, Ling [1 ]
机构
[1] Aix Marseille Univ, Ctr Interdisciplinaire Nanosci Marseille, CNRS, UMR 7325,Equipe Labellisee Ligue Canc, Marseille, France
[2] China Pharmaceut Univ, Ctr Adv Pharmaceut & Biomat, Ctr Drug Discovery, State Key Lab Nat Med, Nanjing, Peoples R China
[3] China Pharmaceut Univ, Ctr Adv Pharmaceut & Biomat, Ctr Drug Discovery, Jiangsu Key Lab Drug Discovery Metab Dis, Nanjing, Peoples R China
[4] Polish Acad Sci, Nencki Inst Expt Biol, Neurobiol Ctr, Lab Mol Neurobiol, Warsaw, Poland
[5] Sapienza Univ Rome, Dept Physiol & Pharmacol, Rome, Italy
[6] Univ Grenoble Alpes, Inst Adv Biosci, CNRS 5309, INSERM,U1209, La Tronche, France
[7] IRCCS Neuromed, Pozzilli, Italy
[8] City Hope Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Monrovia, CA 91016 USA
关键词
JANUS KINASE INHIBITORS; SMALL INTERFERING RNA; IN-VITRO; MECHANISMS; STIMULATION; EFFICIENT; PROTEINS; DESIGN;
D O I
10.1038/s41596-020-00418-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Using siRNAs to genetically manipulate immune cells is important to both basic immunological studies and therapeutic applications. However, siRNA delivery is challenging because primary immune cells are often sensitive to the delivery materials and generate immune responses. We have recently developed an amphiphilic dendrimer that is able to deliver siRNA to a variety of cells, including primary immune cells. We provide here a protocol for the synthesis of this dendrimer, as well as siRNA delivery to immune cells such as primary T and B cells, natural killer cells, macrophages, and primary microglia. The dendrimer synthesis entails straightforward click coupling followed by an amidation reaction, and the siRNA delivery protocol requires simple mixing of the siRNA and dendrimer in buffer, with subsequent application to the primary immune cells to achieve effective and functional siRNA delivery. This dendrimer-mediated siRNA delivery largely outperforms the standard electroporation technique, opening a new avenue for functional and therapeutic studies of the immune system. The whole protocol encompasses the dendrimer synthesis, which takes 10 days; the primary immune cell preparation, which takes 3-10 d, depending on the tissue source and cell type; the dendrimer-mediated siRNA delivery; and subsequent functional assays, which take an additional 3-6 d. Delivery of siRNAs to immune cells is challenging because of these cells' sensitivity to standard transfection reagents. This protocol describes how to synthesize an amphiphilic dendrimer and apply it to transfect siRNAs in a variety of primary immune cells.
引用
收藏
页码:327 / 351
页数:25
相关论文
共 50 条
  • [31] Ionizable Amphiphilic Dendrimer-Based Nanomaterials with Alkyl-Chain-Substituted Amines for Tunable siRNA Delivery to the Liver Endothelium In Vivo
    Khan, Omar F.
    Zaia, Edmond W.
    Yin, Hao
    Bogorad, Roman L.
    Pelet, Jeisa M.
    Webber, Matthew J.
    Zhuang, Iris
    Dahlman, James E.
    Langer, Robert
    Anderson, Daniel G.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2014, 53 (52) : 14397 - 14401
  • [32] Self-assembly of amphiphilic phospholipid peptide dendrimer-based nanovectors for effective delivery of siRNA therapeutics in prostate cancer therapy
    Dong, Yiwen
    Chen, Yu
    Zhu, Dandan
    Shi, Kangjie
    Ma, Chi
    Zhang, Wenjie
    Rocchi, Palma
    Jiang, Lei
    Liu, Xiaoxuan
    JOURNAL OF CONTROLLED RELEASE, 2020, 322 : 416 - 425
  • [33] Amphiphilic dendrimer engineered nanocarrier systems for co-delivery of siRNA and paclitaxel to matrix metalloproteinase-rich tumors for synergistic therapy
    Li, Xin
    Sun, A-ning
    Liu, Yu-jie
    Zhang, Wen-jie
    Pang, Ning
    Cheng, Shi-xuan
    Qi, Xian-rong
    NPG ASIA MATERIALS, 2018, 10 : 238 - 254
  • [34] Characterisation of cationic amphiphilic cyclodextrins for neuronal delivery of siRNA: Effect of reversing primary and secondary face modifications
    O'Mahony, A. M.
    Doyle, D.
    Darcy, R.
    Cryan, J. F.
    O'Driscoll, C. M.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 47 (05) : 896 - 903
  • [35] Amphiphilic dendrimer engineered nanocarrier systems for co-delivery of siRNA and paclitaxel to matrix metalloproteinase-rich tumors for synergistic therapy
    Xin Li
    A-ning Sun
    Yu-jie Liu
    Wen-jie Zhang
    Ning Pang
    Shi-xuan Cheng
    Xian-rong Qi
    NPG Asia Materials, 2018, 10 : 238 - 254
  • [36] Efficient delivery of therapeutic siRNA into glioblastoma cells using multifunctional dendrimer-entrapped gold nanoparticles
    Kong, Lingdan
    Wu, Yilun
    Alves, Carla S.
    Shi, Xiangyang
    NANOMEDICINE, 2016, 11 (23) : 3103 - 3115
  • [37] Regulated and Multiple miRNA and siRNA Delivery Into Primary Cells by a Lentiviral Platform
    Amendola, Mario
    Passerini, Laura
    Pucci, Ferdinando
    Gentner, Bernhard
    Bacchetta, Rosa
    Naldini, Luigi
    MOLECULAR THERAPY, 2009, 17 (06) : 1039 - 1052
  • [38] Regulated and Multiple miRNA and siRNA Delivery into Primary Cells by a Lentiviral Platform
    Amendola, Mario
    Passerini, Laura
    Pucci, Ferdinando
    Gentner, Bernhard
    Bacchetta, Rosa
    Naldini, Luigi
    MOLECULAR THERAPY, 2009, 17 : S160 - S161
  • [39] Tripartite siRNA micelles as controlled delivery systems for primary dendritic cells
    Boudier, Ariane
    Aubert-Pouessel, Anne
    Gerardin, Corine
    Devoisselle, Jean-Marie
    Begu, Sylvie
    Louis-Plence, Pascale
    Quentin, Julie
    Jorgensen, Christian
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2009, 35 (08) : 950 - 958
  • [40] Tripartite siRNA Micelles as Controlled Delivery Systems for Primary Dendritic Cells
    Boudier, Ariane
    Aubert-Pouessel, Anne
    Louis-Plence, Pascale
    Quentin, Julie
    Gerardin, Corine
    Jorgensen, Christian
    Devoisselle, Jean-Marie
    Begu, Sylvie
    HUMAN GENE THERAPY, 2009, 20 (06) : 674 - 674